BioSpace News Archive

Come and join us at the 12th Algae Biomass Organization (ABO) Summit in Texas between October 14th to 17th at Booth #416.

Heidelberg Pharma AG today announced that its partner Magenta Therapeutics (NASDAQ: MGTA), Cambridge, MA, USA, exercises its option to further develop a target molecule, and will now continue the development of an Antibody Targeted Amanitin Conjugate based on the target molecule within an exclusive licensing.

A new study published Friday in JAMA reports that many dietary supplements consumed by people in the United States contain unapproved pharmaceutical ingredients in the over-the-counter products that pose a health risk for unsuspecting consumers.

The U.S. Food and Drug Administration’s Anesthetic and Analgesic Drug Products Advisory Committee voted to recommend AcelRx Pharmaceuticals’ Dsuvia to manage moderate-to-severe pain.

Roche and privately-held cell therapy company SQZ will jointly develop oncology products based on antigen presenting cells (APCs) that are created by the SQZ platform.

Continued expansion and investment to support increasing client demand

Phase III KATHERINE study shows Kadcyla® significantly improved invasive disease-free survival compared to Herceptin® in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment

Phase 2 study aims to reproduce significant efficacy previously observed in schizophrenia trial with xanomeline alone

Medivir AB announced today its plans to concentrate its activities on clinical development.

Newest technology expands company’s GoodWheat™ portfolio of high-value, functional wheat ingredients